JP2005508505A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508505A5 JP2005508505A5 JP2003542649A JP2003542649A JP2005508505A5 JP 2005508505 A5 JP2005508505 A5 JP 2005508505A5 JP 2003542649 A JP2003542649 A JP 2003542649A JP 2003542649 A JP2003542649 A JP 2003542649A JP 2005508505 A5 JP2005508505 A5 JP 2005508505A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- panel
- data set
- gene expression
- profile data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000014509 gene expression Effects 0.000 claims description 295
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 123
- 238000000034 method Methods 0.000 claims description 123
- 206010061218 Inflammation Diseases 0.000 claims description 81
- 230000004054 inflammatory process Effects 0.000 claims description 81
- 238000005259 measurement Methods 0.000 claims description 76
- 239000003814 drug Substances 0.000 claims description 33
- 230000003321 amplification Effects 0.000 claims description 32
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 32
- 230000000875 corresponding effect Effects 0.000 claims description 26
- 229940079593 drug Drugs 0.000 claims description 26
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 claims description 25
- 102100039065 Interleukin-1 beta Human genes 0.000 claims description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 24
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims description 23
- 102100040247 Tumor necrosis factor Human genes 0.000 claims description 23
- 201000010099 disease Diseases 0.000 claims description 22
- 230000004044 response Effects 0.000 claims description 21
- 101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 claims description 20
- 108090000174 Interleukin-10 Proteins 0.000 claims description 20
- 102000003814 Interleukin-10 Human genes 0.000 claims description 20
- 102100020881 Interleukin-1 alpha Human genes 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 16
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 claims description 14
- 102100037850 Interferon gamma Human genes 0.000 claims description 14
- -1 GCG Proteins 0.000 claims description 13
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 13
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims description 13
- 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 claims description 12
- 102000003810 Interleukin-18 Human genes 0.000 claims description 12
- 108090000171 Interleukin-18 Proteins 0.000 claims description 12
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 claims description 11
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims description 11
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 claims description 11
- 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 claims description 11
- 101000959794 Homo sapiens Interferon alpha-2 Proteins 0.000 claims description 10
- 101001097889 Homo sapiens Platelet-activating factor acetylhydrolase Proteins 0.000 claims description 10
- 102100040018 Interferon alpha-2 Human genes 0.000 claims description 10
- 102100037518 Platelet-activating factor acetylhydrolase Human genes 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 235000005911 diet Nutrition 0.000 claims description 6
- 230000037213 diet Effects 0.000 claims description 6
- 230000037081 physical activity Effects 0.000 claims description 6
- 102100037077 Complement C1q subcomponent subunit A Human genes 0.000 claims description 3
- 101000740726 Homo sapiens Complement C1q subcomponent subunit A Proteins 0.000 claims description 3
- 230000002596 correlated effect Effects 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 claims description 2
- 108010028006 B-Cell Activating Factor Proteins 0.000 claims 14
- 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 claims 14
- 108091058560 IL8 Proteins 0.000 claims 13
- 102000004890 Interleukin-8 Human genes 0.000 claims 13
- 108090001007 Interleukin-8 Proteins 0.000 claims 13
- 102100028006 Heme oxygenase 1 Human genes 0.000 claims 12
- 101001079623 Homo sapiens Heme oxygenase 1 Proteins 0.000 claims 12
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 claims 12
- 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 claims 12
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims 12
- 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 claims 12
- 108010037462 Cyclooxygenase 2 Proteins 0.000 claims 11
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 claims 11
- 102000026633 IL6 Human genes 0.000 claims 11
- 108090001005 Interleukin-6 Proteins 0.000 claims 11
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims 11
- 101001019591 Homo sapiens Interleukin-18-binding protein Proteins 0.000 claims 10
- 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 claims 10
- 102000003816 Interleukin-13 Human genes 0.000 claims 10
- 108090000176 Interleukin-13 Proteins 0.000 claims 10
- 102000003812 Interleukin-15 Human genes 0.000 claims 10
- 108090000172 Interleukin-15 Proteins 0.000 claims 10
- 102100035017 Interleukin-18-binding protein Human genes 0.000 claims 10
- 102000000588 Interleukin-2 Human genes 0.000 claims 10
- 108010002350 Interleukin-2 Proteins 0.000 claims 10
- 102000004388 Interleukin-4 Human genes 0.000 claims 10
- 108090000978 Interleukin-4 Proteins 0.000 claims 10
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 claims 10
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 10
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 10
- 102100032937 CD40 ligand Human genes 0.000 claims 9
- 101000868215 Homo sapiens CD40 ligand Proteins 0.000 claims 9
- 101000852992 Homo sapiens Interleukin-12 subunit beta Proteins 0.000 claims 9
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 9
- 101001124991 Homo sapiens Nitric oxide synthase, inducible Proteins 0.000 claims 9
- 101000831616 Homo sapiens Protachykinin-1 Proteins 0.000 claims 9
- 102100036701 Interleukin-12 subunit beta Human genes 0.000 claims 9
- 102000000743 Interleukin-5 Human genes 0.000 claims 9
- 108010002616 Interleukin-5 Proteins 0.000 claims 9
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 9
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 claims 9
- 102100024304 Protachykinin-1 Human genes 0.000 claims 9
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 8
- 102100040352 Heat shock 70 kDa protein 1A Human genes 0.000 claims 8
- 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 claims 8
- 101001037759 Homo sapiens Heat shock 70 kDa protein 1A Proteins 0.000 claims 8
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 8
- 101000738335 Homo sapiens T-cell surface glycoprotein CD3 zeta chain Proteins 0.000 claims 8
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 8
- 102100037906 T-cell surface glycoprotein CD3 zeta chain Human genes 0.000 claims 8
- FOCAHLGSDWHSAH-UHFFFAOYSA-N difluoromethanethione Chemical compound FC(F)=S FOCAHLGSDWHSAH-UHFFFAOYSA-N 0.000 claims 8
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 7
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 7
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims 7
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims 7
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 claims 6
- 108010039343 HLA-DRB1 Chains Proteins 0.000 claims 6
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 claims 6
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 claims 6
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 claims 6
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims 6
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims 6
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 6
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 claims 6
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 claims 6
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 claims 6
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims 6
- 102100031358 Urokinase-type plasminogen activator Human genes 0.000 claims 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 5
- 101000638886 Homo sapiens Urokinase-type plasminogen activator Proteins 0.000 claims 5
- 101000579490 Solanum lycopersicum Suberization-associated anionic peroxidase 1 Proteins 0.000 claims 5
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims 4
- 108091012583 BCL2 Proteins 0.000 claims 4
- 101000990915 Homo sapiens Stromelysin-1 Proteins 0.000 claims 4
- 102100030416 Stromelysin-1 Human genes 0.000 claims 4
- 101001056473 Homo sapiens Keratin, type II cytoskeletal 5 Proteins 0.000 claims 3
- 102100025756 Keratin, type II cytoskeletal 5 Human genes 0.000 claims 3
- 102100027308 Apoptosis regulator BAX Human genes 0.000 claims 2
- 108050006685 Apoptosis regulator BAX Proteins 0.000 claims 2
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims 2
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims 2
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims 2
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 claims 2
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 claims 2
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims 2
- 102100031092 C-C motif chemokine 3 Human genes 0.000 claims 2
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims 2
- 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 claims 2
- 102100039196 CX3C chemokine receptor 1 Human genes 0.000 claims 2
- 102100035904 Caspase-1 Human genes 0.000 claims 2
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims 2
- 102100023226 Early growth response protein 1 Human genes 0.000 claims 2
- 102100031150 Growth arrest and DNA damage-inducible protein GADD45 alpha Human genes 0.000 claims 2
- 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 claims 2
- 101000777387 Homo sapiens C-C motif chemokine 3 Proteins 0.000 claims 2
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims 2
- 101000715398 Homo sapiens Caspase-1 Proteins 0.000 claims 2
- 101001049697 Homo sapiens Early growth response protein 1 Proteins 0.000 claims 2
- 101001066158 Homo sapiens Growth arrest and DNA damage-inducible protein GADD45 alpha Proteins 0.000 claims 2
- 101000614436 Homo sapiens Keratin, type I cytoskeletal 14 Proteins 0.000 claims 2
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 claims 2
- 101000969812 Homo sapiens Multidrug resistance-associated protein 1 Proteins 0.000 claims 2
- 101000861454 Homo sapiens Protein c-Fos Proteins 0.000 claims 2
- 101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 claims 2
- 102100040445 Keratin, type I cytoskeletal 14 Human genes 0.000 claims 2
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 claims 2
- 102100021339 Multidrug resistance-associated protein 1 Human genes 0.000 claims 2
- 102100038494 Nuclear receptor subfamily 1 group I member 2 Human genes 0.000 claims 2
- 108010001511 Pregnane X Receptor Proteins 0.000 claims 2
- 102100027584 Protein c-Fos Human genes 0.000 claims 2
- 108010005173 SERPIN-B5 Proteins 0.000 claims 2
- 108010044012 STAT1 Transcription Factor Proteins 0.000 claims 2
- 102100030333 Serpin B5 Human genes 0.000 claims 2
- 102100029904 Signal transducer and activator of transcription 1-alpha/beta Human genes 0.000 claims 2
- 108010002687 Survivin Proteins 0.000 claims 2
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 claims 2
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 claims 2
- 102100026802 72 kDa type IV collagenase Human genes 0.000 claims 1
- BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 claims 1
- 102100027398 A disintegrin and metalloproteinase with thrombospondin motifs 1 Human genes 0.000 claims 1
- 108091005660 ADAMTS1 Proteins 0.000 claims 1
- 102100027211 Albumin Human genes 0.000 claims 1
- 102100022463 Alpha-1-acid glycoprotein 1 Human genes 0.000 claims 1
- 102100022014 Angiopoietin-1 receptor Human genes 0.000 claims 1
- 102100034524 Apoptotic protease-activating factor 1 Human genes 0.000 claims 1
- 101100129499 Arabidopsis thaliana MAX2 gene Proteins 0.000 claims 1
- 108091007065 BIRCs Proteins 0.000 claims 1
- 108700003785 Baculoviral IAP Repeat-Containing 3 Proteins 0.000 claims 1
- 102100021677 Baculoviral IAP repeat-containing protein 2 Human genes 0.000 claims 1
- 102100021662 Baculoviral IAP repeat-containing protein 3 Human genes 0.000 claims 1
- 102100032412 Basigin Human genes 0.000 claims 1
- 102100032305 Bcl-2 homologous antagonist/killer Human genes 0.000 claims 1
- 102100021971 Bcl-2-interacting killer Human genes 0.000 claims 1
- 102100026596 Bcl-2-like protein 1 Human genes 0.000 claims 1
- 101150008012 Bcl2l1 gene Proteins 0.000 claims 1
- 101150104237 Birc3 gene Proteins 0.000 claims 1
- 101000944273 Bos taurus Inward rectifier potassium channel 2 Proteins 0.000 claims 1
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims 1
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims 1
- 102100028990 C-X-C chemokine receptor type 3 Human genes 0.000 claims 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 1
- 101150065475 C1QA gene Proteins 0.000 claims 1
- 102100031168 CCN family member 2 Human genes 0.000 claims 1
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 1
- 102100032912 CD44 antigen Human genes 0.000 claims 1
- 101150116779 CD82 gene Proteins 0.000 claims 1
- 102100022210 COX assembly mitochondrial protein 2 homolog Human genes 0.000 claims 1
- 102100036364 Cadherin-2 Human genes 0.000 claims 1
- 101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 claims 1
- 108090000397 Caspase 3 Proteins 0.000 claims 1
- 102100029855 Caspase-3 Human genes 0.000 claims 1
- 102100026550 Caspase-9 Human genes 0.000 claims 1
- 102100028003 Catenin alpha-1 Human genes 0.000 claims 1
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 claims 1
- 102000038594 Cdh1/Fizzy-related Human genes 0.000 claims 1
- 102100038504 Cellular retinoic acid-binding protein 2 Human genes 0.000 claims 1
- 102100039537 Claudin-14 Human genes 0.000 claims 1
- 102100033601 Collagen alpha-1(I) chain Human genes 0.000 claims 1
- 102100024335 Collagen alpha-1(VII) chain Human genes 0.000 claims 1
- 108050006400 Cyclin Proteins 0.000 claims 1
- 108010058546 Cyclin D1 Proteins 0.000 claims 1
- 102100025191 Cyclin-A2 Human genes 0.000 claims 1
- 102000009512 Cyclin-Dependent Kinase Inhibitor p15 Human genes 0.000 claims 1
- 108010009356 Cyclin-Dependent Kinase Inhibitor p15 Proteins 0.000 claims 1
- 108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 claims 1
- 108010016788 Cyclin-Dependent Kinase Inhibitor p21 Proteins 0.000 claims 1
- 102100033245 Cyclin-dependent kinase 16 Human genes 0.000 claims 1
- 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 claims 1
- 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 claims 1
- 108010074918 Cytochrome P-450 CYP1A1 Proteins 0.000 claims 1
- 108010074922 Cytochrome P-450 CYP1A2 Proteins 0.000 claims 1
- 108010026925 Cytochrome P-450 CYP2C19 Proteins 0.000 claims 1
- 108010001237 Cytochrome P-450 CYP2D6 Proteins 0.000 claims 1
- 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 claims 1
- 102100031476 Cytochrome P450 1A1 Human genes 0.000 claims 1
- 102100026533 Cytochrome P450 1A2 Human genes 0.000 claims 1
- 102100029363 Cytochrome P450 2C19 Human genes 0.000 claims 1
- 102100021704 Cytochrome P450 2D6 Human genes 0.000 claims 1
- 102100024889 Cytochrome P450 2E1 Human genes 0.000 claims 1
- 102100039205 Cytochrome P450 3A4 Human genes 0.000 claims 1
- 101150082208 DIABLO gene Proteins 0.000 claims 1
- 102100038023 DNA fragmentation factor subunit beta Human genes 0.000 claims 1
- 102100034579 Desmoglein-1 Human genes 0.000 claims 1
- 102100033189 Diablo IAP-binding mitochondrial protein Human genes 0.000 claims 1
- 101001071611 Dictyostelium discoideum Glutathione reductase Proteins 0.000 claims 1
- 102100039104 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit DAD1 Human genes 0.000 claims 1
- 102100037573 Dual specificity protein phosphatase 12 Human genes 0.000 claims 1
- 102100023471 E-selectin Human genes 0.000 claims 1
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 claims 1
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 claims 1
- 102100033902 Endothelin-1 Human genes 0.000 claims 1
- 102100029112 Endothelin-converting enzyme 1 Human genes 0.000 claims 1
- 102100025403 Epoxide hydrolase 1 Human genes 0.000 claims 1
- 102100038595 Estrogen receptor Human genes 0.000 claims 1
- 102100026693 FAS-associated death domain protein Human genes 0.000 claims 1
- 102100037815 Fas apoptotic inhibitory molecule 3 Human genes 0.000 claims 1
- 102100035323 Fibroblast growth factor 18 Human genes 0.000 claims 1
- 102100028071 Fibroblast growth factor 7 Human genes 0.000 claims 1
- 102100037362 Fibronectin Human genes 0.000 claims 1
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 claims 1
- 102100037859 G1/S-specific cyclin-D3 Human genes 0.000 claims 1
- 102100037858 G1/S-specific cyclin-E1 Human genes 0.000 claims 1
- 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 claims 1
- 102000000802 Galectin 3 Human genes 0.000 claims 1
- 108010001517 Galectin 3 Proteins 0.000 claims 1
- 102100039554 Galectin-8 Human genes 0.000 claims 1
- 102100039928 Gamma-interferon-inducible protein 16 Human genes 0.000 claims 1
- 102100021337 Gap junction alpha-1 protein Human genes 0.000 claims 1
- 101710088083 Glomulin Proteins 0.000 claims 1
- 102100040890 Glucagon receptor Human genes 0.000 claims 1
- 102100036264 Glucose-6-phosphatase catalytic subunit 1 Human genes 0.000 claims 1
- 108090000369 Glutamate Carboxypeptidase II Proteins 0.000 claims 1
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 1
- 102100033429 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 1 Human genes 0.000 claims 1
- 102100037473 Glutathione S-transferase A1 Human genes 0.000 claims 1
- 102100037478 Glutathione S-transferase A2 Human genes 0.000 claims 1
- 102100036534 Glutathione S-transferase Mu 1 Human genes 0.000 claims 1
- 102100038055 Glutathione S-transferase theta-1 Human genes 0.000 claims 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 claims 1
- 102100039262 Glycogen [starch] synthase, muscle Human genes 0.000 claims 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 1
- 102100029009 High mobility group protein HMG-I/HMG-Y Human genes 0.000 claims 1
- 101000627872 Homo sapiens 72 kDa type IV collagenase Proteins 0.000 claims 1
- 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 claims 1
- 101000693913 Homo sapiens Albumin Proteins 0.000 claims 1
- 101000678195 Homo sapiens Alpha-1-acid glycoprotein 1 Proteins 0.000 claims 1
- 101000753291 Homo sapiens Angiopoietin-1 receptor Proteins 0.000 claims 1
- 101000924629 Homo sapiens Apoptotic protease-activating factor 1 Proteins 0.000 claims 1
- 101000798441 Homo sapiens Basigin Proteins 0.000 claims 1
- 101000798320 Homo sapiens Bcl-2 homologous antagonist/killer Proteins 0.000 claims 1
- 101000970576 Homo sapiens Bcl-2-interacting killer Proteins 0.000 claims 1
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims 1
- 101000916050 Homo sapiens C-X-C chemokine receptor type 3 Proteins 0.000 claims 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 1
- 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 claims 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 1
- 101000900446 Homo sapiens COX assembly mitochondrial protein 2 homolog Proteins 0.000 claims 1
- 101000714537 Homo sapiens Cadherin-2 Proteins 0.000 claims 1
- 101000983523 Homo sapiens Caspase-9 Proteins 0.000 claims 1
- 101000859063 Homo sapiens Catenin alpha-1 Proteins 0.000 claims 1
- 101001099851 Homo sapiens Cellular retinoic acid-binding protein 2 Proteins 0.000 claims 1
- 101000888570 Homo sapiens Claudin-14 Proteins 0.000 claims 1
- 101000909498 Homo sapiens Collagen alpha-1(VII) chain Proteins 0.000 claims 1
- 101000934320 Homo sapiens Cyclin-A2 Proteins 0.000 claims 1
- 101000944357 Homo sapiens Cyclin-dependent kinase 16 Proteins 0.000 claims 1
- 101000909131 Homo sapiens Cytochrome P450 2E1 Proteins 0.000 claims 1
- 101000950965 Homo sapiens DNA fragmentation factor subunit beta Proteins 0.000 claims 1
- 101000924316 Homo sapiens Desmoglein-1 Proteins 0.000 claims 1
- 101000884921 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit DAD1 Proteins 0.000 claims 1
- 101000924017 Homo sapiens Dual specificity protein phosphatase 1 Proteins 0.000 claims 1
- 101000881110 Homo sapiens Dual specificity protein phosphatase 12 Proteins 0.000 claims 1
- 101000622123 Homo sapiens E-selectin Proteins 0.000 claims 1
- 101001010541 Homo sapiens Electron transfer flavoprotein subunit alpha, mitochondrial Proteins 0.000 claims 1
- 101000925493 Homo sapiens Endothelin-1 Proteins 0.000 claims 1
- 101000841259 Homo sapiens Endothelin-converting enzyme 1 Proteins 0.000 claims 1
- 101001077852 Homo sapiens Epoxide hydrolase 1 Proteins 0.000 claims 1
- 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 claims 1
- 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 claims 1
- 101000878510 Homo sapiens Fas apoptotic inhibitory molecule 3 Proteins 0.000 claims 1
- 101001065295 Homo sapiens Fas-binding factor 1 Proteins 0.000 claims 1
- 101000878128 Homo sapiens Fibroblast growth factor 18 Proteins 0.000 claims 1
- 101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 claims 1
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 claims 1
- 101000738559 Homo sapiens G1/S-specific cyclin-D3 Proteins 0.000 claims 1
- 101000738568 Homo sapiens G1/S-specific cyclin-E1 Proteins 0.000 claims 1
- 101000868643 Homo sapiens G2/mitotic-specific cyclin-B1 Proteins 0.000 claims 1
- 101000608769 Homo sapiens Galectin-8 Proteins 0.000 claims 1
- 101000960209 Homo sapiens Gamma-interferon-inducible protein 16 Proteins 0.000 claims 1
- 101000894966 Homo sapiens Gap junction alpha-1 protein Proteins 0.000 claims 1
- 101001040075 Homo sapiens Glucagon receptor Proteins 0.000 claims 1
- 101000930910 Homo sapiens Glucose-6-phosphatase catalytic subunit 1 Proteins 0.000 claims 1
- 101000997929 Homo sapiens Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 1 Proteins 0.000 claims 1
- 101001026125 Homo sapiens Glutathione S-transferase A1 Proteins 0.000 claims 1
- 101001026115 Homo sapiens Glutathione S-transferase A2 Proteins 0.000 claims 1
- 101001071694 Homo sapiens Glutathione S-transferase Mu 1 Proteins 0.000 claims 1
- 101001032462 Homo sapiens Glutathione S-transferase theta-1 Proteins 0.000 claims 1
- 101001071608 Homo sapiens Glutathione reductase, mitochondrial Proteins 0.000 claims 1
- 101001036130 Homo sapiens Glycogen [starch] synthase, muscle Proteins 0.000 claims 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 1
- 101000840551 Homo sapiens Hexokinase-2 Proteins 0.000 claims 1
- 101000986380 Homo sapiens High mobility group protein HMG-I/HMG-Y Proteins 0.000 claims 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims 1
- 101001077604 Homo sapiens Insulin receptor substrate 1 Proteins 0.000 claims 1
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 claims 1
- 101001044927 Homo sapiens Insulin-like growth factor-binding protein 3 Proteins 0.000 claims 1
- 101001011442 Homo sapiens Interferon regulatory factor 5 Proteins 0.000 claims 1
- 101001076418 Homo sapiens Interleukin-1 receptor type 1 Proteins 0.000 claims 1
- 101000976051 Homo sapiens Involucrin Proteins 0.000 claims 1
- 101000605528 Homo sapiens Kallikrein-2 Proteins 0.000 claims 1
- 101000614442 Homo sapiens Keratin, type I cytoskeletal 16 Proteins 0.000 claims 1
- 101000975496 Homo sapiens Keratin, type II cytoskeletal 8 Proteins 0.000 claims 1
- 101001050577 Homo sapiens Kinesin-like protein KIF2A Proteins 0.000 claims 1
- 101000716729 Homo sapiens Kit ligand Proteins 0.000 claims 1
- 101000605028 Homo sapiens Large neutral amino acids transporter small subunit 3 Proteins 0.000 claims 1
- 101001059644 Homo sapiens MAP kinase-activating death domain protein Proteins 0.000 claims 1
- 101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 claims 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 claims 1
- 101001005550 Homo sapiens Mitogen-activated protein kinase kinase kinase 14 Proteins 0.000 claims 1
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 claims 1
- 101001128156 Homo sapiens Nanos homolog 3 Proteins 0.000 claims 1
- 101001124309 Homo sapiens Nitric oxide synthase, endothelial Proteins 0.000 claims 1
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 claims 1
- 101000603882 Homo sapiens Nuclear receptor subfamily 1 group I member 3 Proteins 0.000 claims 1
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 claims 1
- 101000741788 Homo sapiens Peroxisome proliferator-activated receptor alpha Proteins 0.000 claims 1
- 101000741790 Homo sapiens Peroxisome proliferator-activated receptor gamma Proteins 0.000 claims 1
- 101001120056 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit alpha Proteins 0.000 claims 1
- 101000734572 Homo sapiens Phosphoenolpyruvate carboxykinase, cytosolic [GTP] Proteins 0.000 claims 1
- 101001091365 Homo sapiens Plasma kallikrein Proteins 0.000 claims 1
- 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 claims 1
- 101000583616 Homo sapiens Polyhomeotic-like protein 2 Proteins 0.000 claims 1
- 101001026214 Homo sapiens Potassium voltage-gated channel subfamily A member 5 Proteins 0.000 claims 1
- 101000741967 Homo sapiens Presequence protease, mitochondrial Proteins 0.000 claims 1
- 101001135385 Homo sapiens Prostacyclin synthase Proteins 0.000 claims 1
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims 1
- 101000605534 Homo sapiens Prostate-specific antigen Proteins 0.000 claims 1
- 101001001272 Homo sapiens Prostatic acid phosphatase Proteins 0.000 claims 1
- 101001048456 Homo sapiens Protein Hook homolog 2 Proteins 0.000 claims 1
- 101001051767 Homo sapiens Protein kinase C beta type Proteins 0.000 claims 1
- 101000655540 Homo sapiens Protransforming growth factor alpha Proteins 0.000 claims 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 1
- 101000711466 Homo sapiens SAM pointed domain-containing Ets transcription factor Proteins 0.000 claims 1
- 101000777293 Homo sapiens Serine/threonine-protein kinase Chk1 Proteins 0.000 claims 1
- 101000617823 Homo sapiens Solute carrier organic anion transporter family member 6A1 Proteins 0.000 claims 1
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 claims 1
- 101000716763 Homo sapiens Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Proteins 0.000 claims 1
- 101000839323 Homo sapiens Synaptotagmin-7 Proteins 0.000 claims 1
- 101000655119 Homo sapiens T-cell leukemia homeobox protein 3 Proteins 0.000 claims 1
- 101000801481 Homo sapiens Tissue-type plasminogen activator Proteins 0.000 claims 1
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 claims 1
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims 1
- 101000795107 Homo sapiens Triggering receptor expressed on myeloid cells 1 Proteins 0.000 claims 1
- 101000838456 Homo sapiens Tubulin alpha-1B chain Proteins 0.000 claims 1
- 101000679903 Homo sapiens Tumor necrosis factor receptor superfamily member 25 Proteins 0.000 claims 1
- 101000850748 Homo sapiens Tumor necrosis factor receptor type 1-associated DEATH domain protein Proteins 0.000 claims 1
- 101000762128 Homo sapiens Tumor suppressor candidate 3 Proteins 0.000 claims 1
- 101000823316 Homo sapiens Tyrosine-protein kinase ABL1 Proteins 0.000 claims 1
- 101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 claims 1
- 102100023915 Insulin Human genes 0.000 claims 1
- 102100025087 Insulin receptor substrate 1 Human genes 0.000 claims 1
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims 1
- 102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 claims 1
- 102100030131 Interferon regulatory factor 5 Human genes 0.000 claims 1
- 102100026016 Interleukin-1 receptor type 1 Human genes 0.000 claims 1
- 102100023913 Involucrin Human genes 0.000 claims 1
- 102100038356 Kallikrein-2 Human genes 0.000 claims 1
- 102000057159 Kangai-1 Human genes 0.000 claims 1
- 108700032443 Kangai-1 Proteins 0.000 claims 1
- 102100040441 Keratin, type I cytoskeletal 16 Human genes 0.000 claims 1
- 102100023972 Keratin, type II cytoskeletal 8 Human genes 0.000 claims 1
- 102100023426 Kinesin-like protein KIF2A Human genes 0.000 claims 1
- 102100020880 Kit ligand Human genes 0.000 claims 1
- 108010025026 Ku Autoantigen Proteins 0.000 claims 1
- 102100038269 Large neutral amino acids transporter small subunit 3 Human genes 0.000 claims 1
- 102100028822 MAP kinase-activating death domain protein Human genes 0.000 claims 1
- 102000046961 MRE11 Homologue Human genes 0.000 claims 1
- 108700019589 MRE11 Homologue Proteins 0.000 claims 1
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 claims 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 claims 1
- 102100025211 Mitogen-activated protein kinase kinase kinase 14 Human genes 0.000 claims 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims 1
- 108090000772 Neuropilin-1 Proteins 0.000 claims 1
- 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 claims 1
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 claims 1
- 102100038512 Nuclear receptor subfamily 1 group I member 3 Human genes 0.000 claims 1
- 108091033411 PCA3 Proteins 0.000 claims 1
- BFHAYPLBUQVNNJ-UHFFFAOYSA-N Pectenotoxin 3 Natural products OC1C(C)CCOC1(O)C1OC2C=CC(C)=CC(C)CC(C)(O3)CCC3C(O3)(O4)CCC3(C=O)CC4C(O3)C(=O)CC3(C)C(O)C(O3)CCC3(O3)CCCC3C(C)C(=O)OC2C1 BFHAYPLBUQVNNJ-UHFFFAOYSA-N 0.000 claims 1
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 claims 1
- 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 claims 1
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 claims 1
- 102100026169 Phosphatidylinositol 3-kinase regulatory subunit alpha Human genes 0.000 claims 1
- 102100034796 Phosphoenolpyruvate carboxykinase, cytosolic [GTP] Human genes 0.000 claims 1
- 102100030304 Platelet factor 4 Human genes 0.000 claims 1
- 102100030903 Polyhomeotic-like protein 2 Human genes 0.000 claims 1
- 102100038632 Presequence protease, mitochondrial Human genes 0.000 claims 1
- 102100036691 Proliferating cell nuclear antigen Human genes 0.000 claims 1
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims 1
- 102100033075 Prostacyclin synthase Human genes 0.000 claims 1
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 1
- 102100038358 Prostate-specific antigen Human genes 0.000 claims 1
- 102100035703 Prostatic acid phosphatase Human genes 0.000 claims 1
- 102100032446 Protein S100-A7 Human genes 0.000 claims 1
- 102100024923 Protein kinase C beta type Human genes 0.000 claims 1
- 102100023068 Protein kinase C-binding protein NELL1 Human genes 0.000 claims 1
- 102100032350 Protransforming growth factor alpha Human genes 0.000 claims 1
- 108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 claims 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 1
- 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 claims 1
- 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 claims 1
- 108010005256 S100 Calcium Binding Protein A7 Proteins 0.000 claims 1
- 102100034018 SAM pointed domain-containing Ets transcription factor Human genes 0.000 claims 1
- 108091006299 SLC2A2 Proteins 0.000 claims 1
- 108091006300 SLC2A4 Proteins 0.000 claims 1
- 101100379220 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) API2 gene Proteins 0.000 claims 1
- 101100184049 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MID2 gene Proteins 0.000 claims 1
- 102100031081 Serine/threonine-protein kinase Chk1 Human genes 0.000 claims 1
- 102100027388 Signal recognition particle 19 kDa protein Human genes 0.000 claims 1
- 101710122555 Signal recognition particle 19 kDa protein Proteins 0.000 claims 1
- 102100023537 Solute carrier family 2, facilitated glucose transporter member 2 Human genes 0.000 claims 1
- 102100033939 Solute carrier family 2, facilitated glucose transporter member 4 Human genes 0.000 claims 1
- 102100021991 Solute carrier organic anion transporter family member 6A1 Human genes 0.000 claims 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 1
- 102100020868 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Human genes 0.000 claims 1
- 102100032891 Superoxide dismutase [Mn], mitochondrial Human genes 0.000 claims 1
- 102100028197 Synaptotagmin-7 Human genes 0.000 claims 1
- 102100032568 T-cell leukemia homeobox protein 3 Human genes 0.000 claims 1
- 102000004398 TNF receptor-associated factor 1 Human genes 0.000 claims 1
- 108090000920 TNF receptor-associated factor 1 Proteins 0.000 claims 1
- 108090000925 TNF receptor-associated factor 2 Proteins 0.000 claims 1
- 102100034779 TRAF family member-associated NF-kappa-B activator Human genes 0.000 claims 1
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 claims 1
- 102100024333 Toll-like receptor 2 Human genes 0.000 claims 1
- 102100039360 Toll-like receptor 4 Human genes 0.000 claims 1
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 claims 1
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 claims 1
- 102100029681 Triggering receptor expressed on myeloid cells 1 Human genes 0.000 claims 1
- 102100028969 Tubulin alpha-1B chain Human genes 0.000 claims 1
- 102100028787 Tumor necrosis factor receptor superfamily member 11A Human genes 0.000 claims 1
- 102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 claims 1
- 102100033081 Tumor necrosis factor receptor type 1-associated DEATH domain protein Human genes 0.000 claims 1
- 102100024248 Tumor suppressor candidate 3 Human genes 0.000 claims 1
- 102100022596 Tyrosine-protein kinase ABL1 Human genes 0.000 claims 1
- 108010021111 Uncoupling Protein 2 Proteins 0.000 claims 1
- 102000008219 Uncoupling Protein 2 Human genes 0.000 claims 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims 1
- 108010022133 Voltage-Dependent Anion Channel 1 Proteins 0.000 claims 1
- 102100037820 Voltage-dependent anion-selective channel protein 1 Human genes 0.000 claims 1
- 102100036973 X-ray repair cross-complementing protein 5 Human genes 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 claims 1
- 108700000711 bcl-X Proteins 0.000 claims 1
- 101150073031 cdk2 gene Proteins 0.000 claims 1
- 230000011712 cell development Effects 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 238000007620 mathematical function Methods 0.000 claims 1
- 235000020938 metabolic status Nutrition 0.000 claims 1
- 101150071637 mre11 gene Proteins 0.000 claims 1
- 230000037209 prostate health Effects 0.000 claims 1
- 108010045815 superoxide dismutase 2 Proteins 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 239000000523 sample Substances 0.000 description 101
- 230000002757 inflammatory effect Effects 0.000 description 62
- 210000004369 blood Anatomy 0.000 description 58
- 239000008280 blood Substances 0.000 description 58
- 238000011282 treatment Methods 0.000 description 49
- 239000003795 chemical substances by application Substances 0.000 description 46
- 108090000623 proteins and genes Proteins 0.000 description 44
- 230000006870 function Effects 0.000 description 41
- 239000000203 mixture Substances 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 30
- 241000588724 Escherichia coli Species 0.000 description 26
- 230000000694 effects Effects 0.000 description 26
- 150000001875 compounds Chemical class 0.000 description 25
- 238000004458 analytical method Methods 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 23
- 206010039073 rheumatoid arthritis Diseases 0.000 description 21
- 230000001225 therapeutic effect Effects 0.000 description 18
- 230000036541 health Effects 0.000 description 17
- 208000035473 Communicable disease Diseases 0.000 description 16
- 208000038016 acute inflammation Diseases 0.000 description 14
- 230000006022 acute inflammation Effects 0.000 description 14
- 238000000338 in vitro Methods 0.000 description 14
- 239000000470 constituent Substances 0.000 description 13
- 239000002158 endotoxin Substances 0.000 description 13
- 229920006008 lipopolysaccharide Polymers 0.000 description 13
- 230000000638 stimulation Effects 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 239000002299 complementary DNA Substances 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000003287 optical effect Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 9
- 238000004422 calculation algorithm Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 229960000485 methotrexate Drugs 0.000 description 9
- 229960004618 prednisone Drugs 0.000 description 9
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 9
- 235000004252 protein component Nutrition 0.000 description 9
- 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 8
- 239000002451 tumor necrosis factor inhibitor Substances 0.000 description 8
- 241000191967 Staphylococcus aureus Species 0.000 description 7
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 6
- 238000002123 RNA extraction Methods 0.000 description 6
- 238000012512 characterization method Methods 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 229960001680 ibuprofen Drugs 0.000 description 6
- 239000012678 infectious agent Substances 0.000 description 6
- 238000013507 mapping Methods 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 102100034343 Integrase Human genes 0.000 description 5
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 229940116176 remicade Drugs 0.000 description 5
- 150000003431 steroids Chemical class 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000004544 DNA amplification Effects 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 238000011443 conventional therapy Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000004968 inflammatory condition Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 101150034014 48 gene Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 208000003435 Optic Neuritis Diseases 0.000 description 3
- 108010093965 Polymyxin B Proteins 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 229960003957 dexamethasone Drugs 0.000 description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000027866 inflammatory disease Diseases 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 229920000024 polymyxin B Polymers 0.000 description 3
- 229960005266 polymyxin b Drugs 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000011269 treatment regimen Methods 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010008165 Etanercept Proteins 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 108010047620 Phytohemagglutinins Proteins 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000007940 bacterial gene expression Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940073621 enbrel Drugs 0.000 description 2
- 229940082177 ibuprofen 800 mg Drugs 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000001885 phytohemagglutinin Effects 0.000 description 2
- 238000009101 premedication Methods 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000013643 reference control Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101000795167 Homo sapiens Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 description 1
- 102100040019 Interferon alpha-1/13 Human genes 0.000 description 1
- 101710144554 Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700019961 Neoplasm Genes Proteins 0.000 description 1
- 102000048850 Neoplasm Genes Human genes 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 241000287463 Phalacrocorax Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 101150010487 are gene Proteins 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 239000012911 assay medium Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000002988 disease modifying antirheumatic drug Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 231100000573 exposure to toxins Toxicity 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000005256 gram-negative cell Anatomy 0.000 description 1
- 210000005255 gram-positive cell Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001739 rebound effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 208000012672 seasonal affective disease Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34821301P | 2001-11-09 | 2001-11-09 | |
| US60/348,213 | 2001-11-09 | ||
| US34088101P | 2001-12-07 | 2001-12-07 | |
| US60/340,881 | 2001-12-07 | ||
| US36963302P | 2002-04-03 | 2002-04-03 | |
| US60/369,633 | 2002-04-03 | ||
| US37699702P | 2002-04-30 | 2002-04-30 | |
| US60/376,997 | 2002-04-30 | ||
| PCT/US2002/036084 WO2003040404A1 (en) | 2001-11-09 | 2002-11-08 | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010254661A Division JP2011067214A (ja) | 2001-11-09 | 2010-11-15 | 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005508505A JP2005508505A (ja) | 2005-03-31 |
| JP2005508505A5 true JP2005508505A5 (enExample) | 2013-04-18 |
| JP5236856B2 JP5236856B2 (ja) | 2013-07-17 |
Family
ID=27502635
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003542649A Expired - Lifetime JP5236856B2 (ja) | 2001-11-09 | 2002-11-08 | 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定 |
| JP2010254661A Withdrawn JP2011067214A (ja) | 2001-11-09 | 2010-11-15 | 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010254661A Withdrawn JP2011067214A (ja) | 2001-11-09 | 2010-11-15 | 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US6964850B2 (enExample) |
| EP (1) | EP1451340B1 (enExample) |
| JP (2) | JP5236856B2 (enExample) |
| KR (1) | KR20040064275A (enExample) |
| CN (2) | CN1612936A (enExample) |
| CA (1) | CA2466502A1 (enExample) |
| WO (1) | WO2003040404A1 (enExample) |
Families Citing this family (136)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7473528B2 (en) | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
| US6960439B2 (en) | 1999-06-28 | 2005-11-01 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US6964850B2 (en) | 2001-11-09 | 2005-11-15 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| DE60327737D1 (de) * | 2002-01-22 | 2009-07-09 | Biomatera Inc | Verfahren zur trocknung von biologisch abbaubaren polymeren |
| AU2003299503A1 (en) * | 2002-05-16 | 2004-06-15 | Vanderbilt University | Method for predicting autoimmune diseases |
| MXPA05005073A (es) * | 2002-11-12 | 2005-11-17 | Becton Dickinson Co | Diagnostico de la sepsis o sirs usando perfiles de biomarcadores. |
| MXPA05005072A (es) | 2002-11-12 | 2005-07-22 | Becton Dickinson Co | Diagnostico de la sepsis o sirs usando perfiles de biomarcadores. |
| CA2505921A1 (en) | 2002-11-12 | 2004-05-27 | Becton, Dickinson And Company | Diagnosis of sepsis or sirs using biomarker profiles |
| CA2506066A1 (en) * | 2002-11-15 | 2004-06-03 | Genomic Health, Inc. | Gene expression profiling of egfr positive cancer |
| AU2003303238B2 (en) * | 2002-12-19 | 2010-07-22 | Life Technologies Corporation | Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles |
| US20040231909A1 (en) * | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| WO2004071572A2 (en) * | 2003-02-06 | 2004-08-26 | Genomic Health, Inc. | Gene expression markers for response to egfr inhibitor drugs |
| US20080014579A1 (en) * | 2003-02-11 | 2008-01-17 | Affymetrix, Inc. | Gene expression profiling in colon cancers |
| CA2516553C (en) * | 2003-02-20 | 2013-04-16 | Genomic Health, Inc. | Use of intronic rna to measure gene expression |
| US7892745B2 (en) | 2003-04-24 | 2011-02-22 | Xdx, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| CA2527321A1 (en) * | 2003-05-30 | 2004-12-23 | Genomic Health, Inc. | Gene expression markers for response to egfr inhibitor drugs |
| WO2005039382A2 (en) * | 2003-06-24 | 2005-05-06 | Genomic Health | Prediction of likelihood of cancer recurrence |
| WO2005007892A1 (en) * | 2003-07-03 | 2005-01-27 | Gentron, Llc | Methods and systems for diagnosis of non-cenral nervous system (cns) diseases in cns samples |
| EP1644858B1 (en) | 2003-07-10 | 2017-12-06 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
| EP2128270B1 (en) | 2003-08-08 | 2012-10-03 | Genenews Inc. | Osteoarthritis biomarkers and uses thereof |
| AU2004284434A1 (en) * | 2003-10-16 | 2005-05-06 | Genomic Health, Inc. | qRT-PCR assay system for gene expression profiling |
| JP4718490B2 (ja) * | 2003-12-23 | 2011-07-06 | ジェノミック ヘルス， インコーポレイテッド | フラグメント化ｒｎａの全般的増幅 |
| CA2848463A1 (en) | 2004-04-09 | 2005-10-27 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| US7645575B2 (en) * | 2004-09-08 | 2010-01-12 | Xdx, Inc. | Genes useful for diagnosing and monitoring inflammation related disorders |
| CA3061785A1 (en) | 2004-11-05 | 2006-05-18 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
| JP4939425B2 (ja) * | 2004-11-05 | 2012-05-23 | ジェノミック ヘルス， インコーポレイテッド | 乳癌の治療反応の予後および予測の分子指標 |
| US20060157647A1 (en) * | 2005-01-18 | 2006-07-20 | Becton, Dickinson And Company | Multidimensional liquid chromatography/spectrometry |
| BRPI0609302A2 (pt) | 2005-04-15 | 2011-10-11 | Becton Dickinson Co | métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse |
| WO2006133399A1 (en) | 2005-06-08 | 2006-12-14 | Hitachi Chemical Research Center, Inc. | METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES |
| JP5024583B2 (ja) * | 2005-09-14 | 2012-09-12 | ソニー株式会社 | 情報処理装置および情報処理方法、情報処理システム、プログラム、並びに、記録媒体 |
| KR20090003178A (ko) * | 2006-01-11 | 2009-01-09 | 게노믹 헬쓰, 인코포레이티드 | 직장결장암 예후에 대한 유전자 발현 마커 |
| WO2007123772A2 (en) | 2006-03-31 | 2007-11-01 | Genomic Health, Inc. | Genes involved in estrogen metabolism |
| WO2009070442A2 (en) | 2007-11-14 | 2009-06-04 | Hitachi Chemical Co. Ltd. | Fc receptor-mediated tumor necrosis factor superfamily mrna expression in peripheral blood leukocytes |
| ATE518011T1 (de) | 2006-04-07 | 2011-08-15 | Hitachi Chemical Co Ltd | Erhöhte expression von t- zellenrezeptorvermittelter tumornekrosefaktorsuperfamilie und chemokin-mrna in peripheren blut leukozyten bei patienten mit morbus& xa;crohn |
| EP2021988A2 (en) * | 2006-05-10 | 2009-02-11 | Koninklijke Philips Electronics N.V. | Transforming measurement data for classification learning |
| CA2652239A1 (en) * | 2006-05-16 | 2007-11-29 | Source Mdx | Assessment of effect of an agent on a human biological condition using rodent gene expression panels |
| JP5470848B2 (ja) * | 2006-08-04 | 2014-04-16 | 味の素株式会社 | 肺癌の評価方法、肺癌評価装置、肺癌評価方法、肺癌評価システム、肺癌評価プログラム、記録媒体、および、情報通信端末装置 |
| WO2008021431A2 (en) | 2006-08-14 | 2008-02-21 | Xdx, Inc. | Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders |
| EP2102367A2 (en) | 2006-11-09 | 2009-09-23 | XDX, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| US20090104605A1 (en) * | 2006-12-14 | 2009-04-23 | Gary Siuzdak | Diagnosis of sepsis |
| EP2103940A4 (en) * | 2006-12-21 | 2013-04-24 | Ajinomoto Kk | METHOD, APPARATUS, METHOD, SYSTEM AND SOFTWARE FOR ASSESSING BREAST CANCER, AND RECORDING MEDIUM |
| JPWO2008075664A1 (ja) * | 2006-12-21 | 2010-04-15 | 味の素株式会社 | 癌の評価方法、ならびに癌評価装置、癌評価方法、癌評価システム、癌評価プログラムおよび記録媒体 |
| EP2096439A4 (en) | 2006-12-21 | 2011-01-05 | Ajinomoto Kk | METHOD, APPARATUS, METHOD, SYSTEM AND SOFTWARE FOR EVALUATING COLORECTAL CANCER, AND RECORDING MEDIUM |
| US20090117562A1 (en) | 2007-04-09 | 2009-05-07 | Valerie Wailin Hu | Method and kit for diagnosing Autism using gene expression profiling |
| ES2417148T3 (es) | 2007-06-08 | 2013-08-06 | Genentech, Inc. | Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2 |
| US9551033B2 (en) | 2007-06-08 | 2017-01-24 | Genentech, Inc. | Gene expression markers of tumor resistance to HER2 inhibitor treatment |
| WO2008154532A1 (en) * | 2007-06-11 | 2008-12-18 | California Pacific Medical Center | Method and kit for dynamic gene expression monitoring |
| US8068994B2 (en) * | 2007-07-27 | 2011-11-29 | Wayne State University | Method for analyzing biological networks |
| JP2011511271A (ja) * | 2008-01-25 | 2011-04-07 | サイトテック ラブズ リミテッド ライアビリティ カンパニー | 腫瘍原性、腫瘍進行、および処置効率の査定のためのアッセイシステム |
| KR101272207B1 (ko) * | 2008-02-06 | 2013-06-07 | 아지노모토 가부시키가이샤 | 위암의 평가 방법, 및 위암 평가 장치, 위암 평가 방법, 위암 평가 시스템, 위암 평가 프로그램 및 기록 매체 |
| WO2009123737A2 (en) | 2008-04-03 | 2009-10-08 | Becton, Dickinson And Company | Advanced detection of sepsis |
| US7776522B2 (en) * | 2008-04-24 | 2010-08-17 | Becton, Dickinson And Company | Methods for diagnosing oncogenic human papillomavirus (HPV) |
| EP2294216A4 (en) | 2008-05-14 | 2011-11-23 | Dermtech Int | DIAGNOSIS OF MELANOMA AND SOLAR LENTIGO BY ANALYSIS OF NUCLEIC ACIDS |
| BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
| JP5754136B2 (ja) * | 2008-06-20 | 2015-07-29 | 味の素株式会社 | 女性生殖器癌の評価方法、女性生殖器癌評価装置、女性生殖器癌評価方法、女性生殖器癌評価プログラム、記録媒体、女性生殖器癌評価システム、および情報通信端末装置 |
| JP5754137B2 (ja) | 2008-06-20 | 2015-07-29 | 味の素株式会社 | 前立腺癌の評価方法、前立腺癌評価装置、前立腺癌評価方法、前立腺癌評価プログラム、記録媒体、前立腺癌評価システム、および情報通信端末装置 |
| EP2331707A4 (en) * | 2008-08-28 | 2012-06-06 | Dermtech Int | DETERMINATION OF THE AGING RANGE OF SKIN SAMPLE |
| US8748103B2 (en) | 2008-11-07 | 2014-06-10 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
| US9528160B2 (en) | 2008-11-07 | 2016-12-27 | Adaptive Biotechnolgies Corp. | Rare clonotypes and uses thereof |
| US9365901B2 (en) | 2008-11-07 | 2016-06-14 | Adaptive Biotechnologies Corp. | Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia |
| US8628927B2 (en) | 2008-11-07 | 2014-01-14 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
| US9506119B2 (en) | 2008-11-07 | 2016-11-29 | Adaptive Biotechnologies Corp. | Method of sequence determination using sequence tags |
| US8691510B2 (en) | 2008-11-07 | 2014-04-08 | Sequenta, Inc. | Sequence analysis of complex amplicons |
| GB2483810B (en) | 2008-11-07 | 2012-09-05 | Sequenta Inc | Methods for correlating clonotypes with diseases in a population |
| US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| US9580752B2 (en) | 2008-12-24 | 2017-02-28 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy |
| PT2387627E (pt) | 2009-01-15 | 2016-06-03 | Adaptive Biotechnologies Corp | Determinação do perfil de imunidade adaptativa e métodos de geração de anticorpos monoclonais |
| WO2010127322A1 (en) * | 2009-05-01 | 2010-11-04 | Genomic Health Inc. | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy |
| JP2012531202A (ja) | 2009-06-25 | 2012-12-10 | フレッド ハチンソン キャンサー リサーチ センター | 適応免疫を測定する方法 |
| US9043160B1 (en) | 2009-11-09 | 2015-05-26 | Sequenta, Inc. | Method of determining clonotypes and clonotype profiles |
| CN103237901B (zh) | 2010-03-01 | 2016-08-03 | 卡里斯生命科学瑞士控股有限责任公司 | 用于治疗诊断的生物标志物 |
| CA2795776A1 (en) | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers for disease |
| JP5755326B2 (ja) | 2010-06-11 | 2015-07-29 | 日立化成株式会社 | 腎機能の特徴を決定する方法 |
| WO2011156734A2 (en) * | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Method of characterizing vascular diseases |
| MX338883B (es) | 2010-07-27 | 2016-05-04 | Genomic Health Inc | Metodo para usar expresion de gen para determinar el pronostico de cancer de prostata. |
| WO2012021714A2 (en) * | 2010-08-12 | 2012-02-16 | William Marsh Rice University | Biomarker signatures for wellness testing |
| US10011876B2 (en) | 2010-11-23 | 2018-07-03 | Krisani Biosciences Pvt. Ltd | Method and system for prognosis and treatment of diseases using portfolio of genes |
| US20140032125A1 (en) * | 2011-02-12 | 2014-01-30 | Siemens Healthcare Diagnostics Inc. | Environment and Method for Rapid Analysis of Genomic Sequence Data |
| WO2012170037A1 (en) | 2011-06-10 | 2012-12-13 | Hitachi Chemical Co., Ltd. | Vesicle capturing devices and methods for using same |
| US10385475B2 (en) | 2011-09-12 | 2019-08-20 | Adaptive Biotechnologies Corp. | Random array sequencing of low-complexity libraries |
| EP2768982A4 (en) | 2011-10-21 | 2015-06-03 | Adaptive Biotechnologies Corp | QUANTIFICATION OF ADAPTIVE IMMUNOCELL GENOMES IN A COMPLEX MIX OF CELLS |
| ES2926726T3 (es) | 2011-11-14 | 2022-10-27 | Aushon Biosystems Inc | Sistemas y métodos para mejorar la consistencia del rendimiento de un ensayo |
| AU2012347460B2 (en) | 2011-12-09 | 2017-05-25 | Adaptive Biotechnologies Corporation | Diagnosis of lymphoid malignancies and minimal residual disease detection |
| US9499865B2 (en) | 2011-12-13 | 2016-11-22 | Adaptive Biotechnologies Corp. | Detection and measurement of tissue-infiltrating lymphocytes |
| SG11201404390WA (en) | 2012-01-31 | 2014-08-28 | Genomic Health Inc | Gene expression profile algorithm and test for determining prognosis of prostate cancer |
| JP6302847B2 (ja) | 2012-03-05 | 2018-03-28 | アダプティヴ バイオテクノロジーズ コーポレーション | 頻度が一致したサブユニットからの、対をなす免疫受容体鎖の決定 |
| ES2711156T3 (es) | 2012-05-08 | 2019-04-30 | Adaptive Biotechnologies Corp | Método para medir y calibrar el sesgo de amplificación en reacciones de PCR multiplexadas |
| JP6219934B2 (ja) | 2012-05-22 | 2017-10-25 | バーグ エルエルシー | 薬物誘発毒性マーカーを同定するための照合による細胞に基づくアッセイ |
| FR2993282B1 (fr) * | 2012-07-13 | 2017-11-10 | Expanscience Lab | Procede d'identification de marqueurs moleculaires de la peau d'enfant |
| EP2895861A4 (en) * | 2012-09-12 | 2016-06-22 | Berg Llc | USE OF MARKERS FOR THE IDENTIFICATION OF CARDIOTOXIC AGENTS |
| WO2014043581A1 (en) * | 2012-09-14 | 2014-03-20 | Life Technologies Corporation | Methods and systems for a digital pcr experiment designer |
| EP2904111B1 (en) | 2012-10-01 | 2017-12-06 | Adaptive Biotechnologies Corporation | Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization |
| EP3639841B1 (en) | 2013-03-27 | 2023-09-06 | Cedars-Sinai Medical Center | Treating fibrosis by inhibiting tl1a |
| DE212013000295U1 (de) | 2013-05-06 | 2016-02-02 | Hitachi Chemical Co. America, Ltd. | Vorrichtungen zum Einfangen von Zielmolekülen |
| US9708657B2 (en) | 2013-07-01 | 2017-07-18 | Adaptive Biotechnologies Corp. | Method for generating clonotype profiles using sequence tags |
| EP3022295A4 (en) | 2013-07-19 | 2017-03-01 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
| JP6703479B2 (ja) | 2013-12-16 | 2020-06-03 | フィリップ モリス プロダクツ エス アー | 個人の喫煙ステータスを予測するためのシステムおよび方法 |
| CA2935720A1 (en) * | 2014-01-16 | 2015-07-23 | Illumina, Inc. | Gene expression panel for prognosis of prostate cancer recurrence |
| US11578373B2 (en) | 2019-03-26 | 2023-02-14 | Dermtech, Inc. | Gene classifiers and uses thereof in skin cancers |
| US20170292149A1 (en) | 2014-03-05 | 2017-10-12 | Adaptive Biotechnologies Corporation | Methods using randomer-containing synthetic molecules |
| US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
| ES2777529T3 (es) | 2014-04-17 | 2020-08-05 | Adaptive Biotechnologies Corp | Cuantificación de genomas de células inmunitarias adaptativas en una mezcla compleja de células |
| EP3172564A4 (en) * | 2014-07-18 | 2018-06-27 | Genova Diagnostics, Inc. | Use of an evidence-based, translational algorithm to, inter alia, assess biomarkers |
| WO2016069886A1 (en) | 2014-10-29 | 2016-05-06 | Adaptive Biotechnologies Corporation | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples |
| US10266895B2 (en) | 2014-11-05 | 2019-04-23 | Hitachi Chemical Company Ltd. | Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease |
| WO2016077537A1 (en) | 2014-11-12 | 2016-05-19 | Hitachi Chemical Co., Ltd. | Method and device for diagnosing organ injury |
| US10246701B2 (en) | 2014-11-14 | 2019-04-02 | Adaptive Biotechnologies Corp. | Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture |
| CA2968543C (en) | 2014-11-25 | 2024-04-02 | Adaptive Biotechnologies Corporation | Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing |
| WO2016138122A1 (en) | 2015-02-24 | 2016-09-01 | Adaptive Biotechnologies Corp. | Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing |
| WO2016161273A1 (en) | 2015-04-01 | 2016-10-06 | Adaptive Biotechnologies Corp. | Method of identifying human compatible t cell receptors specific for an antigenic target |
| CN108271422A (zh) | 2015-06-25 | 2018-07-10 | 株式会社国际电气通信基础技术研究所 | 基于器官间串扰系统的预测装置及预测程序 |
| JP6867959B2 (ja) * | 2015-07-13 | 2021-05-12 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 病院環境における感染の追跡 |
| WO2017040520A1 (en) | 2015-08-31 | 2017-03-09 | Hitachi Chemical Co., Ltd. | Molecular methods for assessing urothelial disease |
| CN105279397B (zh) * | 2015-10-26 | 2017-12-19 | 华东交通大学 | 一种识别蛋白质相互作用网络中关键蛋白质的方法 |
| KR101795662B1 (ko) * | 2015-11-19 | 2017-11-13 | 연세대학교 산학협력단 | 대사 이상 질환 진단 장치 및 그 방법 |
| JP7082945B2 (ja) | 2016-03-17 | 2022-06-09 | シーダーズ―シナイ メディカル センター | Ｒｎａｓｅｔ２により炎症性腸疾患を診断する方法 |
| JP6432962B2 (ja) | 2016-03-29 | 2018-12-05 | 株式会社国際電気通信基礎技術研究所 | 腎機能低下、慢性腎疾患及び腎不全からなる群から選択される少なくとも一種の疾患を予防、又は治療するための有効成分の候補物質のスクリーニング方法 |
| JP6332780B2 (ja) | 2016-03-29 | 2018-05-30 | 株式会社国際電気通信基礎技術研究所 | 医薬組成物又は食品組成物、及び有効成分の体内での効果の評価方法 |
| US10607720B2 (en) | 2016-05-11 | 2020-03-31 | International Business Machines Corporation | Associating gene expression data with a disease name |
| US10428325B1 (en) | 2016-09-21 | 2019-10-01 | Adaptive Biotechnologies Corporation | Identification of antigen-specific B cell receptors |
| CN106709267A (zh) * | 2017-01-25 | 2017-05-24 | 武汉贝纳科技服务有限公司 | 数据获取方法及装置 |
| CN107058521B (zh) * | 2017-03-17 | 2019-12-27 | 中国科学院北京基因组研究所 | 一种检测人体免疫状态的检测系统 |
| JPWO2019066044A1 (ja) | 2017-09-29 | 2020-12-10 | ファーマバイオ株式会社 | 標準化発現量を利用した再生医療製品等の品質管理の手法 |
| US11254980B1 (en) | 2017-11-29 | 2022-02-22 | Adaptive Biotechnologies Corporation | Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements |
| US11976332B2 (en) | 2018-02-14 | 2024-05-07 | Dermtech, Inc. | Gene classifiers and uses thereof in non-melanoma skin cancers |
| EP3762506A4 (en) * | 2018-02-21 | 2022-03-23 | Edifice Health, Inc. | METHOD OF MEASURING AGING DUE TO CHRONIC SYSTEMIC INFLAMMATION |
| EP3765853B1 (en) * | 2018-03-13 | 2024-05-01 | Creatv Microtech, Inc. | Methods for monitoring treatment response and disease progression in subjects using circulating cells |
| WO2019193241A1 (en) * | 2018-04-03 | 2019-10-10 | Nokia Technologies Oy | Use of band combination index for definition of carrier aggregation configurations |
| KR102170726B1 (ko) * | 2018-10-04 | 2020-10-27 | 사회복지법인 삼성생명공익재단 | 바이오마커의 선별 방법 및 이를 이용한 암의 진단을 위한 정보제공방법 |
| KR102875526B1 (ko) * | 2019-03-26 | 2025-10-22 | 제이에프이 스틸 가부시키가이샤 | 프로세스 상태 감시 장치 및 프로세스 상태 감시 방법 |
| US20230003719A1 (en) * | 2019-12-13 | 2023-01-05 | Janssen Biotech, Inc. | Materials and methods for inflammatory molecular markers |
| US20250230502A1 (en) * | 2022-03-30 | 2025-07-17 | National Cancer Center | Ifi16 mutant gene as a marker for risk prediction, diagnosis or prognosis of chronic liver disease and uses thereof |
| CN118298911B (zh) * | 2024-04-12 | 2024-11-22 | 中山大学孙逸仙纪念医院 | 一种多部位慢性疼痛潜在治疗靶点确定系统 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5580722A (en) * | 1989-07-18 | 1996-12-03 | Oncogene Science, Inc. | Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease |
| US5569601A (en) * | 1990-12-07 | 1996-10-29 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | Human dopamine receptor and its uses |
| US6114114A (en) | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
| JP3509100B2 (ja) * | 1993-01-21 | 2004-03-22 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 哺乳動物のストレスプロモーターを利用する化合物の毒性測定方法および診断用キット |
| US5643765A (en) | 1993-04-06 | 1997-07-01 | University Of Rochester | Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
| DK0695361T4 (da) * | 1993-04-21 | 2010-03-22 | Univ Edinburgh | Ekspression af heterologe gener ifølge en målekspressionsprofil |
| US6309823B1 (en) * | 1993-10-26 | 2001-10-30 | Affymetrix, Inc. | Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same |
| US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| US5506145A (en) * | 1994-12-02 | 1996-04-09 | Bull; Brian S. | Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements |
| US5693646A (en) * | 1994-12-22 | 1997-12-02 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| US5968770A (en) * | 1995-02-10 | 1999-10-19 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| US6022683A (en) * | 1996-12-16 | 2000-02-08 | Nova Molecular Inc. | Methods for assessing the prognosis of a patient with a neurodegenerative disease |
| US5866330A (en) * | 1995-09-12 | 1999-02-02 | The Johns Hopkins University School Of Medicine | Method for serial analysis of gene expression |
| US5922184A (en) | 1997-07-21 | 1999-07-13 | Bio-Rad Laboratories, Inc. | Computer-directed detection of paraproteins |
| FR2775984B1 (fr) | 1998-03-11 | 2006-09-15 | Bioscreen Therapeutics Sa | Criblage differentiel qualitatif |
| EP0910666B1 (en) | 1996-05-02 | 2006-08-09 | Applera Corporation | Quantitation of rna transcripts using genomic dna as the internal amplification competitor |
| US5955269A (en) * | 1996-06-20 | 1999-09-21 | Rutgers, The State University Of New Jersey | Methods of screening foods for nutraceuticals |
| US6146828A (en) * | 1996-08-14 | 2000-11-14 | Exact Laboratories, Inc. | Methods for detecting differences in RNA expression levels and uses therefor |
| EP0960214A4 (en) | 1996-12-06 | 2004-08-04 | Urocor Inc | Diagnosis of disease status on HAnd from mRNA profiles |
| JPH10261029A (ja) | 1996-12-16 | 1998-09-29 | Nissho Corp | アルツハイマー病生涯罹病性の予測システム |
| US5968784A (en) * | 1997-01-15 | 1999-10-19 | Chugai Pharmaceutical Co., Ltd. | Method for analyzing quantitative expression of genes |
| US6165709A (en) * | 1997-02-28 | 2000-12-26 | Fred Hutchinson Cancer Research Center | Methods for drug target screening |
| US5994076A (en) * | 1997-05-21 | 1999-11-30 | Clontech Laboratories, Inc. | Methods of assaying differential expression |
| AU9217198A (en) | 1997-09-03 | 1999-03-22 | Oncormed | Method for predicting prognosis and treatment response for genetically based abnormalities |
| DE69829402T2 (de) | 1997-10-31 | 2006-04-13 | Affymetrix, Inc. (a Delaware Corp.), Santa Clara | Expressionsprofile in adulten und fötalen organen |
| JP3784162B2 (ja) | 1998-01-14 | 2006-06-07 | 株式会社日立製作所 | Ｄｎａ断片分析法 |
| PT1068528E (pt) | 1998-02-25 | 2006-12-29 | Us Gov Health & Human Serv | Método e aparato para reparar uma série para o estabelecimento rápido de perfis moleculares |
| JP2002512046A (ja) | 1998-04-23 | 2002-04-23 | ジェネンテック・インコーポレーテッド | 遺伝子発現の定量的分析 |
| EP1075485A4 (en) | 1998-05-05 | 2004-12-15 | Gene Logic Inc | METHOD FOR STUDYING MODIFICATIONS OF GENE EXPRESSION IN T CELLS |
| US6232065B1 (en) * | 1998-05-06 | 2001-05-15 | Case Western Reserve University | Analysis of gene family expression |
| US6324479B1 (en) * | 1998-05-08 | 2001-11-27 | Rosetta Impharmatics, Inc. | Methods of determining protein activity levels using gene expression profiles |
| JP2002514804A (ja) | 1998-05-12 | 2002-05-21 | ロゼッタ インファーマティクス， インコーポレーテッド | 遺伝子発現分析のための数値化方法、システムおよび装置 |
| US6218122B1 (en) * | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
| US6132969A (en) * | 1998-06-19 | 2000-10-17 | Rosetta Inpharmatics, Inc. | Methods for testing biological network models |
| ATE253126T1 (de) | 1998-08-25 | 2003-11-15 | Univ Washington | Schnelle quantitative analyse von proteinen oder proteinfunktionen in komplexen gemischen |
| US6185561B1 (en) * | 1998-09-17 | 2001-02-06 | Affymetrix, Inc. | Method and apparatus for providing and expression data mining database |
| US6245517B1 (en) * | 1998-09-29 | 2001-06-12 | The United States Of America As Represented By The Department Of Health And Human Services | Ratio-based decisions and the quantitative analysis of cDNA micro-array images |
| US20010055760A1 (en) | 1998-10-13 | 2001-12-27 | Alex Chenchik | Nucleic acid arrays |
| US6203987B1 (en) * | 1998-10-27 | 2001-03-20 | Rosetta Inpharmatics, Inc. | Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
| AU777624B2 (en) | 1998-11-05 | 2004-10-21 | Ortho-Mcneil Pharmaceutical, Inc. | Method for generating gene expression profiles |
| US6222093B1 (en) * | 1998-12-28 | 2001-04-24 | Rosetta Inpharmatics, Inc. | Methods for determining therapeutic index from gene expression profiles |
| WO2000058728A1 (fr) * | 1999-03-26 | 2000-10-05 | Uno, Akitane | Moyen d'examen precoce de tumeur maligne |
| WO2000066259A1 (en) * | 1999-05-05 | 2000-11-09 | Ut-Battelle, Llc | Method and apparatus for combinatorial chemistry |
| DK1630709T3 (da) | 1999-05-25 | 2009-12-07 | Aventis Pharma Inc | Matematisk analyse til estimering af ændringer i niveauet af reportergen |
| DK1198585T3 (da) * | 1999-06-28 | 2007-10-15 | Source Precision Medicine Inc | Fremgangsmåde til karakterisering af en biologisk tilstand ved anvendelse af kalibrerede genudtrykkelsesprofiler |
| AU6533700A (en) | 1999-08-09 | 2001-03-05 | Affymetrix, Inc. | Methods of gene expression monitoring |
| CA2381777C (en) | 1999-08-12 | 2011-10-04 | Wisconsin Alumni Research Foundation | Identification of genetic markers of biological age and metabolism |
| WO2001020998A1 (en) | 1999-09-24 | 2001-03-29 | Linden Technologies, Inc. | Drug discovery using gene expression profiling |
| US6505125B1 (en) | 1999-09-28 | 2003-01-07 | Affymetrix, Inc. | Methods and computer software products for multiple probe gene expression analysis |
| AU1179001A (en) | 1999-10-13 | 2001-04-23 | Plant Research International B.V. | Method for detecting differences in gene expression between wild type plants andnewly developed plants |
| US6607885B1 (en) | 1999-10-15 | 2003-08-19 | E. I. Du Pont De Nemours And Company | Method for high-density microarray medicated gene expression profiling |
| EP1287162A2 (en) | 1999-10-21 | 2003-03-05 | Case Western Reserve University | Gene expression profiling of inflammatory bowel disease |
| MXPA02004241A (es) | 1999-10-26 | 2002-10-17 | Digital Gene Tech Inc | Regulacion de la expresion de genes por agentes neurolepticos. |
| AU1466001A (en) | 1999-11-05 | 2001-05-14 | Phase-1 Molecular Toxicology | Methods of determining individual hypersensitivity to an agent |
| US6248535B1 (en) | 1999-12-20 | 2001-06-19 | University Of Southern California | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
| WO2001075162A2 (en) * | 2000-03-31 | 2001-10-11 | University Of Louisville Research Foundation, Inc. | Microarrays to screen regulatory genes |
| US7384736B2 (en) * | 2001-09-06 | 2008-06-10 | Decode Genetics Ehf. | Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease |
| US6964850B2 (en) | 2001-11-09 | 2005-11-15 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
-
2002
- 2002-11-08 US US10/291,856 patent/US6964850B2/en not_active Expired - Lifetime
- 2002-11-08 WO PCT/US2002/036084 patent/WO2003040404A1/en not_active Ceased
- 2002-11-08 CN CNA02826908XA patent/CN1612936A/zh active Pending
- 2002-11-08 JP JP2003542649A patent/JP5236856B2/ja not_active Expired - Lifetime
- 2002-11-08 EP EP02792239.2A patent/EP1451340B1/en not_active Expired - Lifetime
- 2002-11-08 KR KR10-2004-7007103A patent/KR20040064275A/ko not_active Ceased
- 2002-11-08 CA CA002466502A patent/CA2466502A1/en not_active Abandoned
- 2002-11-08 CN CN2011102265910A patent/CN102402650A/zh active Pending
-
2005
- 2005-06-22 US US11/158,504 patent/US20050287576A1/en not_active Abandoned
-
2009
- 2009-10-30 US US12/609,578 patent/US8055452B2/en not_active Expired - Fee Related
-
2010
- 2010-11-15 JP JP2010254661A patent/JP2011067214A/ja not_active Withdrawn
-
2011
- 2011-09-21 US US13/239,070 patent/US8718946B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5236856B2 (ja) | 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定 | |
| JP2005508505A5 (enExample) | ||
| US7957909B2 (en) | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles | |
| US20180060481A1 (en) | Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles | |
| US7935482B2 (en) | Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis | |
| AU784233B2 (en) | Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles | |
| US20100305058A1 (en) | Individualized cancer treatments | |
| JP2010227111A (ja) | 遺伝子発現プロフィールを用いる、感染症の同定、モニタリング、および処置、ならびに感染症に関連する炎症状態の特徴付け | |
| US20040225449A1 (en) | Systems and methods for characterizing a biological condition or agent using selected gene expression profiles | |
| JP2006510382A5 (enExample) | ||
| AU2003303238A2 (en) | Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles | |
| Hammamieh et al. | Modeling of SEB-induced host gene expression to correlate in vitro to in vivo responses | |
| Gambardella et al. | Deep learning models reading clinical data and liver omics strongly distinguish NASH from steatosis and suggest new genes involved in liver disease severity | |
| Mondry et al. | DNA expression microarrays may be the wrong tool to identify biological pathways | |
| HK1169190A (en) | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |